
The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling
Keywords: AngII; angiotensin II; ANOVA; analysis of variance; ANP; atrial natriuretic peptide; DH404; dihydro-CDDO-trifluoroethyl amide; eNOS; endothelial nitric oxide synthase; Grx1; glutaredoxin 1; GSS; glutathionylation; Keap1; Kelch-like erythroid cell-derived